Bladder Cancer
Seiten
2011
|
Softcover reprint of the original 1st ed. 1985
Springer London Ltd (Verlag)
978-1-4471-1364-5 (ISBN)
Springer London Ltd (Verlag)
978-1-4471-1364-5 (ISBN)
Cancer of the bladder has a bad reputation: the combination of urinary problems and malignancy gives just cause for continuing concern. Early bladder cancer is amenable to several therapeutic approaches, but we have still to determine the best approach.
Cancer of the bladder has a bad reputation: the combination of urinary problems and malignancy gives just cause for continuing concern. Not only is this common cancer a burden to the patient but, because of the need for regular follow-up, it creates a large workload on the urological services. It might be imagined that the bladder would give early warning signals of disease, and indeed it may do so; yet it can also be hesitant to reveal its severity. Thus there are many problems that create challenges in the diagnosis and management. Prevention is still the first goal of an oncologist, with early detection of early disease being the next best option. Early bladder cancer is amenable to several therapeutic approaches, but we have still to determine the best approach. The management of more advanced invasive bladder cancer all too often leads to disappointment, and we remain uncertain as to the optimum approach-surgery, radiotherapy, chemotherapy or some combination of these. Although none of these problems may be fully answered either now or in the near future, many people are working towards their solution, and the rate of progress needs to be documented from time to time. This volume aims to set the standard for the present state of our knowledge on bladder cancer. The editors, Professor Ernst Zingg and Mr'. Michael Wallace, have gathered together the best opinions on a wide range of topics relating to bladder cancer.
Cancer of the bladder has a bad reputation: the combination of urinary problems and malignancy gives just cause for continuing concern. Not only is this common cancer a burden to the patient but, because of the need for regular follow-up, it creates a large workload on the urological services. It might be imagined that the bladder would give early warning signals of disease, and indeed it may do so; yet it can also be hesitant to reveal its severity. Thus there are many problems that create challenges in the diagnosis and management. Prevention is still the first goal of an oncologist, with early detection of early disease being the next best option. Early bladder cancer is amenable to several therapeutic approaches, but we have still to determine the best approach. The management of more advanced invasive bladder cancer all too often leads to disappointment, and we remain uncertain as to the optimum approach-surgery, radiotherapy, chemotherapy or some combination of these. Although none of these problems may be fully answered either now or in the near future, many people are working towards their solution, and the rate of progress needs to be documented from time to time. This volume aims to set the standard for the present state of our knowledge on bladder cancer. The editors, Professor Ernst Zingg and Mr'. Michael Wallace, have gathered together the best opinions on a wide range of topics relating to bladder cancer.
1 The Epidemiology and Aetiology of Bladder Cancer.- 2 The Histopathology of Bladder Cancer.- 3 Immunological Aspects of Bladder Cancer.- 4 Symptomatology.- 5 Diagnostic Procedures.- 6 Classification of Bladder Tumours.- 7 Carcinoma In Situ.- 8 The Treatment of Superficial Bladder Tumours.- 9 The Treatment of Muscle Invasive Bladder Cancer.- 1 Surgery.- 2 Radiotherapy.- 3 Primary Surgery Approach.- 4 Primary Radiotherapy Approach.- 10 Chemotherapy of Bladder Cancer.- 11 Palliative Treatment.
Reihe/Serie | Clinical Practice in Urology |
---|---|
Zusatzinfo | XII, 301 p. |
Verlagsort | England |
Sprache | englisch |
Maße | 170 x 244 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Urologie | |
Schlagworte | Cancer |
ISBN-10 | 1-4471-1364-0 / 1447113640 |
ISBN-13 | 978-1-4471-1364-5 / 9781447113645 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Korrigierter Nachdruck 2020 mit allen Ergänzungen der UICC aus den …
Buch | Softcover (2020)
Wiley-VCH (Verlag)
CHF 59,95
Resilienz innovativ stärken : ein Praxishandbuch
Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 49,95